KOR

e-Article

Preliminary Results of a Phase I Study of the Pan-PI3 Kinase Inhibitor SF1126 in Patients with Relapsed and Refractory Myeloma.
Document Type
Abstract
Source
In Blood 20 November 2009 114(22):3879-3879
Subject
Language
ISSN
0006-4971